Emcure Pharmaceuticals Ltd shares fall 1.17% as Board composition changes
Why did Emcure Pharmaceuticals Ltd shares fall today?
Emcure Pharmaceuticals Ltd shares fell by 1.17% today, closing at ₹1936.1 on Thursday at 04:06 PM. The decline in the share price followed an important announcement from the company regarding a change in its top leadership.
The company informed stock exchanges that its Board of Directors met today and noted the resignation of Mr. Berjis Desai. He was serving as the Chairman and Non-executive, Non-Independent Director. Mr. Desai, who was due for re-appointment at the upcoming Annual General Meeting, decided not to seek re-appointment. His reason for stepping down is a new role as a member of the National Commission for Minorities in New Delhi.
Following his resignation, the board has approved the appointment of Mr. Raghu Kumar as an Additional Director. He will take on the position of Non-Executive and Independent Director. This transition in the company's board composition, as disclosed under regulatory requirements, likely contributed to the market's reaction and the subsequent fall in Emcure's share price today.
What does Emcure Pharmaceuticals Ltd do?
Emcure Pharmaceuticals Ltd is a company listed on the National Stock Exchange of India and the BSE Limited. The company's script symbol is EMCURE and its scrip code is 544210.
The company's Board of Directors held a meeting on August 06, 2026. During this meeting, the Board noted the decision of Mr. Berjis Desai, the Chairman and Non-executive, Non-Independent Director, to not seek re-appointment at the upcoming Annual General Meeting. His decision is due to his appointment as a member of the National Commission for Minorities in New Delhi.
Emcure Pharmaceuticals Ltd Financials
In CroresEmcure Pharmaceuticals Ltd's revenue grew from ₹2363.48 crores in December 2025 to ₹2469.7 crores in March 2026, representing an increase of approximately 4.5%. Correspondingly, the company's profit also showed an upward trend, rising from ₹230.54 crores to ₹243.4 crores over the same period, a growth of about 5.6%. Both key financial indicators demonstrate positive momentum between the two reported quarters.
Emcure Pharmaceuticals Ltd Shareholding Pattern
Promoter holding stands at 77.83% of the total share capital. Foreign Institutional Investors (FIIs) hold 4.87% stake in the company, while Domestic Institutional Investors (DIIs) hold 8.46%. Public shareholders hold the remaining 8.84% stake in Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd FAQs
Q: Why did Emcure shares fall 1.17% today?
Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015 - Change in composition of the Board of the Company. This corporate action caught investor attention, leading to increased trading activity in the stock.
Q: What is the shareholding pattern of Emcure Pharmaceuticals Ltd?
As per the latest data, promoters hold 77.83% stake in Emcure Pharmaceuticals Ltd, while FII holding stands at 4.87%. Domestic institutional investors hold 8.46%, and public shareholders account for 8.84% of the equity.
Q: What is the current stock price of Emcure Pharmaceuticals Ltd?
Emcure Pharmaceuticals Ltd shares are currently trading at ₹1936.1, recording a decline of 1.17% from the previous close.
Q: What is the market capitalization of Emcure Pharmaceuticals Ltd?
The company currently has a market capitalization of ₹36723.97 crore, reflecting its valuation in the Indian equity market.